APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Yellow Nail Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Yellow Nail Syndrome Treatment Industry Growth and Trends Forecast to 2032

Report ID 174048380131 December 2025110 pages

Choose your research edition.

Industry ResearchYellow Nail Syndrome Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Yellow Nail Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Yellow Nail Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Yellow Nail Syndrome Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Yellow Nail Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Yellow Nail Syndrome Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Yellow Nail Syndrome Treatment market include Abbott, Sanofi, Johnson & Johnson, Novartis, Merck, Merck, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Yellow Nail Syndrome Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Yellow Nail Syndrome Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Yellow Nail Syndrome Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Yellow Nail Syndrome Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Yellow Nail Syndrome Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Yellow Nail Syndrome Treatment Market by Company

Abbott

Sanofi

Johnson & Johnson

Novartis

Merck

Merck

Mylan

Roche

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Teva Pharmaceutical

Sun Pharmaceutical

Sumitomo Corporation

Enzon Pharmaceuticals

Cipla

Allergan

Yellow Nail Syndrome Treatment Segment by Type

Capsule

Cream

Tablet

Injection

Others

Yellow Nail Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Yellow Nail Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Nail Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Nail Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Nail Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Yellow Nail Syndrome Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Yellow Nail Syndrome Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Yellow Nail Syndrome Treatment Market Share by Region (2021-2026) Table 4. Global Yellow Nail Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Yellow Nail Syndrome Treatment Market Share by Region (2027-2032) Table 6. Global Yellow Nail Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2026) Table 9. Global Yellow Nail Syndrome Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Yellow Nail Syndrome Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Yellow Nail Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2026) Table 24. Global Yellow Nail Syndrome Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Yellow Nail Syndrome Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Yellow Nail Syndrome Treatment Industry Trends Table 37. Yellow Nail Syndrome Treatment Industry Drivers Table 38. Yellow Nail Syndrome Treatment Industry Opportunities and Challenges Table 39. Yellow Nail Syndrome Treatment Industry Restraints Table 40. Global Yellow Nail Syndrome Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Yellow Nail Syndrome Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Yellow Nail Syndrome Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Yellow Nail Syndrome Treatment Key Company Headquarters & Area Served Table 44. Global Yellow Nail Syndrome Treatment Company, Product Type & Application Table 45. Global Yellow Nail Syndrome Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Yellow Nail Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Yellow Nail Syndrome Treatment Product Portfolio Table 52. Abbott Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Yellow Nail Syndrome Treatment Product Portfolio Table 57. Sanofi Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Yellow Nail Syndrome Treatment Product Portfolio Table 67. Novartis Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 72. Merck Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 77. Merck Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Mylan Yellow Nail Syndrome Treatment Product Portfolio Table 82. Mylan Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Yellow Nail Syndrome Treatment Product Portfolio Table 87. Roche Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Yellow Nail Syndrome Treatment Product Portfolio Table 92. Pfizer Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bayer Yellow Nail Syndrome Treatment Product Portfolio Table 102. Bayer Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio Table 107. AstraZeneca Recent Development Table 108. Teva Pharmaceutical Company Information Table 109. Teva Pharmaceutical Business Overview Table 110. Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 112. Teva Pharmaceutical Recent Development Table 113. Sun Pharmaceutical Company Information Table 114. Sun Pharmaceutical Business Overview Table 115. Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 117. Sun Pharmaceutical Recent Development Table 118. Sumitomo Corporation Company Information Table 119. Sumitomo Corporation Business Overview Table 120. Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio Table 122. Sumitomo Corporation Recent Development Table 123. Enzon Pharmaceuticals Company Information Table 124. Enzon Pharmaceuticals Business Overview Table 125. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio Table 127. Enzon Pharmaceuticals Recent Development Table 128. Cipla Company Information Table 129. Cipla Business Overview Table 130. Cipla Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Cipla Yellow Nail Syndrome Treatment Product Portfolio Table 132. Cipla Recent Development Table 133. Allergan Company Information Table 134. Allergan Business Overview Table 135. Allergan Yellow Nail Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Allergan Yellow Nail Syndrome Treatment Product Portfolio Table 137. Allergan Recent Development Table 138. North America Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Yellow Nail Syndrome Treatment Market Share by Country (2021-2026) Table 141. North America Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Yellow Nail Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 143. Europe Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Yellow Nail Syndrome Treatment Market Share by Country (2021-2026) Table 146. Europe Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Yellow Nail Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Yellow Nail Syndrome Treatment Market Share by Country (2021-2026) Table 151. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Yellow Nail Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 153. Latin America Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Yellow Nail Syndrome Treatment Market Share by Country (2021-2026) Table 156. Latin America Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Yellow Nail Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Country (2021-2026) Table 161. Middle East & Africa Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Yellow Nail Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Yellow Nail Syndrome Treatment Product Image Figure 3. Global Yellow Nail Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Yellow Nail Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Yellow Nail Syndrome Treatment Market Share by Region (2021-2032) Figure 7. North America Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Capsule Image Figure 13. Global Capsule Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cream Image Figure 15. Global Cream Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Tablet Image Figure 17. Global Tablet Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Injection Image Figure 19. Global Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Yellow Nail Syndrome Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Yellow Nail Syndrome Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinic Image Figure 32. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Yellow Nail Syndrome Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Yellow Nail Syndrome Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Yellow Nail Syndrome Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Yellow Nail Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Yellow Nail Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 47. Europe Yellow Nail Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Yellow Nail Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Yellow Nail Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Yellow Nail Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 53. Latin America Yellow Nail Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Yellow Nail Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Cream
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Merck
  • Mylan
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sumitomo Corporation
  • Enzon Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Yellow Nail Syndrome Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Yellow Nail Syndrome Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Yellow Nail Syndrome Treatment Market Size (2021-2032)
  8. 1.5.1 North America Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Yellow Nail Syndrome Treatment Market Size Growth Rate (2021-2032)
2 Yellow Nail Syndrome Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Capsule
  3. 2.1.2 Cream
  4. 2.1.3 Tablet
  5. 2.1.4 Injection
  6. 2.1.5 Others
  7. 2.2 Global Yellow Nail Syndrome Treatment Market Size by Type
  8. 2.2.1 Global Yellow Nail Syndrome Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Yellow Nail Syndrome Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Yellow Nail Syndrome Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Yellow Nail Syndrome Treatment Market Size by Regions
  12. 2.3.1 North America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Type (2021-2026)
3 Yellow Nail Syndrome Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Yellow Nail Syndrome Treatment Market Size by Application
  6. 3.2.1 Global Yellow Nail Syndrome Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Yellow Nail Syndrome Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Yellow Nail Syndrome Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Yellow Nail Syndrome Treatment Market Size by Regions
  10. 3.3.1 North America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Yellow Nail Syndrome Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Yellow Nail Syndrome Treatment Industry Trends
  2. 4.2 Yellow Nail Syndrome Treatment Industry Drivers
  3. 4.3 Yellow Nail Syndrome Treatment Industry Opportunities and Challenges
  4. 4.4 Yellow Nail Syndrome Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Yellow Nail Syndrome Treatment Revenue (2021-2026)
  2. 5.2 Global Yellow Nail Syndrome Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Yellow Nail Syndrome Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Yellow Nail Syndrome Treatment Company, Product Type & Application
  5. 5.5 Global Yellow Nail Syndrome Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Yellow Nail Syndrome Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Yellow Nail Syndrome Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Yellow Nail Syndrome Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Yellow Nail Syndrome Treatment Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Yellow Nail Syndrome Treatment Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Yellow Nail Syndrome Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Yellow Nail Syndrome Treatment Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Yellow Nail Syndrome Treatment Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Yellow Nail Syndrome Treatment Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bayer Yellow Nail Syndrome Treatment Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 AstraZeneca
  68. 6.12.1 AstraZeneca Company Information
  69. 6.12.2 AstraZeneca Business Overview
  70. 6.12.3 AstraZeneca Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio
  72. 6.12.5 AstraZeneca Recent Developments
  73. 6.13 Teva Pharmaceutical
  74. 6.13.1 Teva Pharmaceutical Company Information
  75. 6.13.2 Teva Pharmaceutical Business Overview
  76. 6.13.3 Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  78. 6.13.5 Teva Pharmaceutical Recent Developments
  79. 6.14 Sun Pharmaceutical
  80. 6.14.1 Sun Pharmaceutical Company Information
  81. 6.14.2 Sun Pharmaceutical Business Overview
  82. 6.14.3 Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Recent Developments
  85. 6.15 Sumitomo Corporation
  86. 6.15.1 Sumitomo Corporation Company Information
  87. 6.15.2 Sumitomo Corporation Business Overview
  88. 6.15.3 Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio
  90. 6.15.5 Sumitomo Corporation Recent Developments
  91. 6.16 Enzon Pharmaceuticals
  92. 6.16.1 Enzon Pharmaceuticals Company Information
  93. 6.16.2 Enzon Pharmaceuticals Business Overview
  94. 6.16.3 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio
  96. 6.16.5 Enzon Pharmaceuticals Recent Developments
  97. 6.17 Cipla
  98. 6.17.1 Cipla Company Information
  99. 6.17.2 Cipla Business Overview
  100. 6.17.3 Cipla Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Cipla Yellow Nail Syndrome Treatment Product Portfolio
  102. 6.17.5 Cipla Recent Developments
  103. 6.18 Allergan
  104. 6.18.1 Allergan Company Information
  105. 6.18.2 Allergan Business Overview
  106. 6.18.3 Allergan Yellow Nail Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Allergan Yellow Nail Syndrome Treatment Product Portfolio
  108. 6.18.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Yellow Nail Syndrome Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst